Hosts Blake Williamson, MD, MPH, and Gary Wörtz, MD, invite Erik L. Mertens, MD, FEBOphth, and Gregory D. Parkhurst, MD, FACS, to share their experiences with the recently FDA-approved EVO Visian ICL (STAAR Surgical). The surgeons discuss the excitement surrounding this technology, and Drs. Mertens and Parkhurst provide insights into the ideal patient candidates for this procedure and how ophthalmic surgeons can start to incorporate the EVO into their practices.